1. HMGA1 Overexpression is Associated With the Malignant Status and Progression of Breast Cancer
    Cuiling Qi et al, 2018, Anat. Rec. CrossRef
  2. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR
    Yue-ya Liang et al, 2018, World J Surg Onc CrossRef
  3. Bortezomib inhibited the progression of diffuse large B-cell lymphoma via targeting miR-198
    Ruihuan Wang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  4. SIRT1 alleviates isoniazid-induced hepatocyte injury by reducing histone acetylation in the IL-6 promoter region.
    Yiyang Zhang et al, 2019, Int Immunopharmacol CrossRef
  5. HMGA1 in cancer: Cancer classification by location
    Yuhong Wang et al, 2019, J Cell Mol Med CrossRef
  6. Survival and Clinicopathological Significance of SIRT1 Expression in Cancers: A Meta-Analysis
    Min Sun et al, 2019, Front. Endocrinol. CrossRef
  7. SIRT1: a potential tumour biomarker and therapeutic target
    Bin Zhao et al, 2019, Journal of Drug Targeting CrossRef
  8. Sirt1 protects from K‐Ras‐driven lung carcinogenesis
    Luis Filipe Costa‐Machado et al, 2018, EMBO Rep CrossRef
  9. Differential expression of the sirtuin family in renal cell carcinoma: Aspects of carcinogenesis and prognostic significance
    Seong Uk Jeh et al, 2017, Urologic Oncology: Seminars and Original Investigations CrossRef
  10. Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma
    Xue Wen et al, 2019, Dig Dis Sci CrossRef
  11. Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy
    Renata Veselska et al, 2019, Front. Oncol. CrossRef
  12. Prognostic and clinicopathological significance of SIRT1 expression in NSCLC: a meta-analysis.
    Yifei Chen et al, 2017, Oncotarget CrossRef
  13. Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining
    Wen-Jie Chen et al, 2017, Oncotarget CrossRef
  14. Deregulation of a Cis-Acting lncRNA in Non-small Cell Lung Cancer May Control HMGA1 Expression
    Greg L. Stewart et al, 2021, Front. Genet. CrossRef
  15. GRP75 ‐mediated upregulation of HMGA1 stimulates stage I lung adenocarcinoma progression by activating JNK / c‐JUN signaling
    Guo‐Bing Qiao et al, 2021, Thorac Cancer CrossRef
  16. Discovering the Protective Effects of Resveratrol on Aflatoxin B1-Induced Toxicity: A Whole Transcriptomic Study in a Bovine Hepatocyte Cell Line
    Marianna Pauletto et al, 2021, Antioxidants CrossRef
  17. SIRT1 induces the accumulation of TAMs at colorectal cancer tumor sites via the CXCR4/CXCL12 axis
    Hongsheng Fang et al, 2022, Cellular Immunology CrossRef
  18. Prognostic Significance of HMGA1 Expression in Lung Cancer Based on Bioinformatics Analysis
    Lias Saed et al, 2022, IJMS CrossRef
  19. HMGA1 gene expression level in cancer tissue and blood samples of non-small cell lung cancer (NSCLC) patients: preliminary report
    Lias Saed et al, 2022, Mol Genet Genomics CrossRef